Refine
Has Fulltext
- yes (130)
Is part of the Bibliography
- yes (130)
Year of publication
- 2023 (130) (remove)
Document Type
- Doctoral Thesis (130)
Keywords
- Tissue Engineering (6)
- Angststörung (5)
- Thrombozyt (5)
- Biene (4)
- Funktionelle Kernspintomografie (4)
- Maus (4)
- Zellzyklus (4)
- Immunologie (3)
- Makrophage (3)
- Melanom (3)
- Mikroskopie (3)
- Neurodegeneration (3)
- Platelet (3)
- Small RNA (3)
- Zellskelett (3)
- fMRI (3)
- platelets (3)
- ADHD (2)
- Altern (2)
- Alzheimerkrankheit (2)
- Aufmerksamkeit (2)
- Biofabrication (2)
- Biomarker (2)
- Bortezomib (2)
- Brain-derived neurotrophic factor (2)
- CRISPR/Cas-Methode (2)
- CRISPR/Cas9 (2)
- Campylobacter jejuni (2)
- Cement (2)
- Cytoskeleton (2)
- Dünndarm (2)
- Endothel (2)
- Epigenetik (2)
- Expansion Microscopy (2)
- Expositionstherapie (2)
- Fibromyalgie (2)
- Galectine (2)
- Gephyrin (2)
- Graft-versus-host-disease (2)
- Immunsuppression (2)
- Induzierte pluripotente Stammzelle (2)
- Inhibitorische Synapse (2)
- Inhibitory synapse (2)
- Interleukin 6 (2)
- Kernspintomografie (2)
- Kognition (2)
- Krebs <Medizin> (2)
- MMB (2)
- Monarchfalter (2)
- Neurofascin (2)
- Neuroinflammation (2)
- Neurowissenschaften (2)
- Organische Synthese (2)
- Orientierung (2)
- Parkinson-Krankheit (2)
- Peptidsynthese (2)
- Pflanzen (2)
- Regulatorischer T-Lymphozyt (2)
- Ribosom (2)
- SPECT (2)
- Schlaganfall (2)
- Sepsis (2)
- Spinale Muskelatrophie (2)
- Stammzelle (2)
- Transkriptomanalyse (2)
- Transplantat-Wirt-Reaktion (2)
- Zellmigration (2)
- Zement (2)
- bee (2)
- division of labor (2)
- gephyrin (2)
- honeybee (2)
- ischemic stroke (2)
- 18S rRNA (1)
- 3 D bioprinting (1)
- 3D Gewebemodelle (1)
- 3D Printing (1)
- 3D cell culture (1)
- 3D tissue model (1)
- 3D-Druck (1)
- 3D-Zellkultur (1)
- ATR-FTIR (1)
- Actin cytoskeleton-related protein (1)
- Adjuvans (1)
- Adrenocortical Carcinoma (1)
- Affinity probe (1)
- Agoraphobie (1)
- Aktivierungsenergie (1)
- Akzeptanz (1)
- Akzeptanz- und Commitment Therapie (1)
- Allogenic hematopoietic stem cell transplantation (1)
- Alternative zum Tierversuch (1)
- Alzheimer's Dementia (1)
- Alzheimer's disease (1)
- AmGr1, AmGr2, AmGr3 (1)
- Amygdala (1)
- Angst (1)
- Angst als Zustand (1)
- Angsterkrankung (1)
- Animal model (1)
- Anxiety disorder (1)
- Anxiety disorders (1)
- Apis mellifera (1)
- Apoptosis (1)
- Arteriosklerose (1)
- Arzneimitteldesign (1)
- Aspergillus fumigatus (1)
- Atemwege (1)
- Atemwegsschleimhaut (1)
- Atherogenese (1)
- Atherosclerosis (1)
- Atherosklerose (1)
- Attentional bias (1)
- Aufmerksamkeitsdefizit-Syndrom (1)
- Aufmerksamkeitsprozesse (1)
- Aurora-A (1)
- Aurora-A-MYCN-Komplex (1)
- Autoantikörper (1)
- Autoinhibition (1)
- Awareness (1)
- B-MYB (1)
- B-Zell-Lymphom (1)
- BDNF stimulation (1)
- BOLD signal (1)
- BRET (1)
- Bacterial infection (1)
- Baghdadite (1)
- Bakterielle Infektion (1)
- Bandwürmer (1)
- Bauchspeicheldrüse (1)
- Bauchspeicheldrüsenkrebs (1)
- Bed nucleus of stria terminalis (1)
- Benzimidazolderivate (1)
- Bestärkendes Lernen <Künstliche Intelligenz> (1)
- Bildgebendes Verfahren (1)
- Bimolekulare Lipidschicht (1)
- Bindegewebe (1)
- Bioinformatics (1)
- Biologie (1)
- Biomechanics (1)
- Biomechanik (1)
- Bioreactor (1)
- Blick (1)
- Blood nerve barrier (1)
- Blut-Hirn-Schranke (1)
- Bone-replacement (1)
- Brownsche Bewegung (1)
- CA3 (1)
- CD28 Superagonist (1)
- CIDP (1)
- CMV (1)
- CVT (1)
- CXCR4 (1)
- CYP24A1 (1)
- CYP7A1 (1)
- Cadherine (1)
- Calcium Phosphate (1)
- Calciumphosphat (1)
- Cell adhesion (1)
- Cell cycle (1)
- Characterization (1)
- Chemokin CXCL12 (1)
- Chemotherapie (1)
- Children (1)
- Cholesterinstoffwechsel (1)
- Chromatin (1)
- Chronische Niereninsuffizienz (1)
- Circadian (1)
- Clostridium difficile (1)
- Comorbidity (1)
- Contactin-1 (1)
- Corpus amygdaloideum (1)
- Correlative microscopy (1)
- Coxiella burnetii (1)
- Crosstalk (1)
- Cytomegalie-Virus (1)
- Cytotoxic T cell (1)
- DHX30 (1)
- DNS-Reparatur (1)
- DNS-Schädigung (1)
- Danaus plexippus (1)
- Deep-sequencing (1)
- Dendritische Zelle (1)
- Dendritische Zellen (1)
- Dephosphorylierung (1)
- Depression (1)
- Diabetic painful neuropathy (1)
- Diagnostik (1)
- Diffusion coefficient (1)
- Dorsal root ganglion (1)
- Dual-setting (1)
- Dynamics of ribosome assembly (1)
- ER dynamics in axon terminals (1)
- Echinococcus (1)
- Echokardiographie (1)
- Echtzeit (1)
- Ecological Momentary Assessment (1)
- Einfühlung (1)
- Einfühlung <Motiv> (1)
- Einsamkeit (1)
- Einzelzellanalyse (1)
- Elektrophysiologie (1)
- Emotionsregulation (1)
- Endocytose (1)
- Endocytosis (1)
- Endophänotypen (1)
- Endoplasmatisches Retikulum (1)
- Endosomes (1)
- Endothelium (1)
- Endozytose (1)
- Enterobacteriaceae (1)
- Entzündung (1)
- Erregbarkeit (1)
- Excitatory/inhibitory imbalance (1)
- Exposure treatment (1)
- Expression (1)
- Extinktion (1)
- Extrazellulärmatrix (1)
- Exzitatorische Synapse (1)
- FAT10ylation (1)
- FOXP2 (1)
- FRET (1)
- Fabry disease (1)
- Fabry-Krankheit (1)
- Fear generalization (1)
- Fettleber (1)
- Fettsäurestoffwechsel (1)
- Fibromyalgia syndrome (1)
- Fibromyalgiesyndrom (1)
- Flavonoids (1)
- FluidFM (1)
- Fluorescence Microscopy (1)
- Fluorescence microscopy (1)
- Fluorescent probes (1)
- Fluoreszenz-Resonanz-Energie-Transfer (1)
- Fluoreszenzmikroskopie (1)
- Fluoreszenzsonde (1)
- Forkhead Transcription Factors (1)
- Forkhead-Box-Proteine (1)
- FoxO transcription factors (1)
- Freies Molekül (1)
- Fructosebisphosphat-Aldolase (1)
- Frühe Gene (1)
- Fuchsbandwurm (1)
- Furchtentwicklung (1)
- Furchtgeneralisierung (1)
- Furchtkonditionierung (1)
- Fusobacterium nucleatum (1)
- Förster Resonanz Energie Transfer (1)
- G-Protein gekoppelter Rezeptor (1)
- G2/M genes (1)
- GAD1 (1)
- GC1 cells (1)
- GLA KO mouse model (1)
- GPCR (1)
- GRM8 (1)
- Galectin 1 (1)
- Ganzkörperbestrahlung (1)
- Gas chromatography (1)
- Gaschromatographie (1)
- Gehirn (1)
- Genetic etiology (1)
- Genexpression (1)
- Genomics (1)
- Genotyping (1)
- Genregulation (1)
- Germinative Zellen (1)
- Gewebemodell (1)
- Gewebemodelle (1)
- Glioblastoma (1)
- Glucocorticoids (1)
- Glycocalyx (1)
- Glykane (1)
- Glykobiologie (1)
- Glykokalyx (1)
- Graft-versus-host disease (GvHD) (1)
- Graft-versus-leukemia (1)
- Gram-positive (1)
- Granulozyten (1)
- Guanine nucleotide exchange factor (GEF) (1)
- GvL (1)
- Gvhd (1)
- HASH (1)
- HCMV (1)
- HPLC-MS (1)
- Habituationstraining (1)
- Hautleitfähigkeit (1)
- Hautmodell (1)
- Helicobacter pylori (1)
- Herpes (1)
- Herz (1)
- Herzfrequenz (1)
- Herzfunktion (1)
- Herzinfarkt (1)
- Herzinsuffizienz (1)
- Herzmuskel (1)
- Heterogenität von Mikroorganismen (1)
- Hfq (1)
- Hippocampus (1)
- Homing (1)
- Humanparasitologie (1)
- Hybrid-Molecules (1)
- Hyperactivity (1)
- Hypothalamus (1)
- IE3 (1)
- IL-2 (1)
- IP6 (1)
- IVIG (1)
- Ibrutinib (1)
- Image Quality (1)
- Immune Checkpoint Therapy (1)
- Immune System (1)
- Immune cell assays (1)
- Immunkardiologie (1)
- Immunocardiology (1)
- Immunology (1)
- Immunotherapy (1)
- Immunsystem (1)
- Immuntherapie (1)
- Immunzellassays (1)
- Impulsivität (1)
- In-vitro-Kultur (1)
- Induced pluripotent stem cells (1)
- Infection models (1)
- Infectious diseases (1)
- Infektiologie (1)
- Infektionsmodell (1)
- Infektionsstudien (1)
- Inhibitor (1)
- Inhibitory-postsynapse (1)
- Injectability (1)
- Insekten (1)
- Integrin (1)
- Interaktion (1)
- Interleukin 2 (1)
- Internalisierende Störung (1)
- Isolation and Characterization (1)
- K-Ras (1)
- Kardiologie (1)
- Keratinozyt (1)
- Kind (1)
- Kinderpsychiatrie (1)
- Kindesalter (1)
- Knochenersatz (1)
- Knochenmark (1)
- Knochenmarktransplantation (1)
- Knochenmetastase (1)
- Knochenmetastasen (1)
- Kohlenhydrate (1)
- Kolloid (1)
- Komorbidität (1)
- Komplement <Immunologie> (1)
- Komplementsystem (1)
- Koronare Herzkrankheit (1)
- Korrelative Mikroskopie (1)
- Krebsforschung (1)
- Kutikula (1)
- Körperachsen (1)
- Körperliche Leistungsfähigkeit (1)
- Künstliche Ingelligenz (1)
- Ldlr-Knockout (1)
- Lebensmittelchemie (1)
- Leukaemia-inhibitory factor (1)
- Library of Phytochemicals (1)
- Library of plant species (1)
- Lidschlag (1)
- Locomotor activity (1)
- Lungenkrebs (1)
- Lysosome (1)
- MAP-Kinase (1)
- MCMV (1)
- MEK5/ERK5 cascade (1)
- MRT (1)
- MYC (1)
- MYCN (1)
- Macrophages (1)
- Malignant melanoma (1)
- Mantle cell lymphoma (1)
- Maschinelles Lernen (1)
- Massenspektrometrie (1)
- Masspectrometry (1)
- Mausmodell (1)
- Megakaryozyt (1)
- Melt electrowriting (1)
- Metabolic Glycoengineering (1)
- Metastase (1)
- Microscopy (1)
- Microwave Assisted Extraction (1)
- Mikrotubuli (1)
- Mikrotubuli-assoziiertes Protein (MAP) (1)
- Mitose (1)
- Modellierung (1)
- Moderator (1)
- Modification (1)
- ModulationTregs (1)
- Molekulare Bildgebung (1)
- Monoklonale Gammopathie (1)
- Morbus Fabry (1)
- Motoneuron (1)
- Motoneuron-Krankheit (1)
- Multi-Unit Aufnahmen (1)
- Multidrugresistant (1)
- Multilayered skin tissue model (1)
- Multiples Myelom (1)
- Myc (1)
- Myeloid-derived suppressor cells (1)
- Myocardial infarction (1)
- Myokardiale Deformation (1)
- Myosin IIA (1)
- NA (1)
- NAFLD (1)
- NEDMIAL (1)
- NFAT (1)
- NFATc1 (1)
- NFATc3 (1)
- NMR (1)
- NaV1.9 (1)
- Narrow escape problem (1)
- Natriumkanal (1)
- Nature-Insipired Synthesis (1)
- Naturstoff (1)
- Nebenniere (1)
- Nebennierenrindenkarzinom (1)
- Nebennierentumor (1)
- Nervenstimulation (1)
- Neurodevelopmental diseases (1)
- Neuroepigenomics (1)
- Neuromodulation (1)
- Neuropathic pain (1)
- Neuropathie (1)
- Neuroprotection (1)
- Neuroscience (1)
- Neutrophils (1)
- Nicht-kleinzelliges Bronchialkarzinom (NSCLC) (1)
- Nociceptor (1)
- Non-coding RNA (1)
- Noonan-Syndrom (1)
- Olfaktorik (1)
- Onchocerca volvulus (1)
- Onchozerkose (1)
- Oncogenes (1)
- Oncostatin M (1)
- Optogenetics (1)
- Optogenetik (1)
- Osmr-Knockout (1)
- Oxytocin (1)
- PAR-CLIP (1)
- PD-L1 (1)
- PEG (1)
- PER (1)
- PGE2 (1)
- PROTAC (1)
- PTH1R (1)
- Panikstörung (1)
- Pankreas (1)
- Paranodopathie (1)
- Parasitology (1)
- Parkinson's disease (1)
- Pathogenesis (1)
- Pathogenität (1)
- Pathophysiologie (1)
- Peptide (1)
- Peripheral eosinophils (1)
- Peripheres Nervensystem (1)
- Pesticide (1)
- Peyersche Plaques (1)
- Phosphoglykolatphosphatase (1)
- Phospholipide (1)
- Phylogenie (1)
- Phylogeny (1)
- Plant extracts (1)
- Plants (1)
- Plasmozytom (1)
- Plastin 3 (1)
- Platelets (1)
- Platy (1)
- Polymere (1)
- Polymers (1)
- Polyneuropathie (1)
- Polysaccharide (1)
- Prognose (1)
- Programmed Cell Death 1 (1)
- Programmed Cell Death Ligand 1 (1)
- Proliferation (1)
- Promotor (1)
- Prosoziales Verhalten (1)
- Prostaglandin E2 (1)
- Proteasom (1)
- Proteasome (1)
- Protein-Protein-Wechselwirkung (1)
- Proteintyrosinphosphatase (1)
- Proteolysis-Targeting-Chimera (1)
- Pseudouridin (1)
- RAMP (1)
- RIL-seq (1)
- RIM1α (1)
- RNA helicase (1)
- RNA metabolism (1)
- RNA modifications (1)
- RNA-Protein Interaktom (1)
- RNA-RNA interactions (1)
- RNA-Sequenzierung (1)
- RNA-bindendes Protein (1)
- RNA-protein interactome (1)
- RNS-Bindungsproteine (1)
- RNS-Viren (1)
- Random Forest (1)
- Random-walk simulations (1)
- Ranvier-Schnürring (1)
- Rbm8a (1)
- Reaktive Sauerstoffspezies (1)
- Regenerative Medizin (1)
- Regulation (1)
- Regulatory T Cells (1)
- Rekonsolidierung (1)
- Reproducibility challenges (1)
- Reprogrammming (1)
- Rezeptor (1)
- Rezeptor-Tyrosinkinasen (1)
- Rheology (1)
- Rho GTPasw (1)
- Rho-Kinasen (1)
- RhoA (1)
- Rodents (1)
- SARS-CoV-2 (1)
- SET7 (1)
- SPECT/CT (1)
- STAAB study (1)
- STAAB-Studie (1)
- SUMOylation (1)
- Salmonella (1)
- Satellite glial cell (1)
- Scherstress (1)
- Schlaf (1)
- Schmerz (1)
- Schmerzforschung (1)
- Schmetterlinge (1)
- Schwertkärpfling (1)
- Schädel-Hirn-Trauma (1)
- Sehen (1)
- Sekundärkrankheit (1)
- Sequence-Structure (1)
- Sequenzdaten (1)
- Serotonin (1)
- Setting Control (1)
- Shear Stress (1)
- Silica precursor (1)
- Single-cell RNA Sequencing (1)
- Single-cell RNA-sequencing (1)
- Sinusthrombose (1)
- Skin Tissue Engineering (1)
- Sleep (1)
- Social Buffering (1)
- Social Distancing (1)
- Sol-gel (1)
- Solid-phase peptide synthesis (1)
- Sozialer Kontakt (1)
- Specialized pro resolving mediators (1)
- Speckle Tracking (1)
- Spinal Muscular Atrophy (1)
- Spinalganglion (1)
- Spo0A (1)
- Sporenbildung (1)
- Sporulation (1)
- Spred-Proteine (1)
- Stammzelltransplantation (1)
- Steroide (1)
- Steroidhormon (1)
- Stimulationsversuche (1)
- Stroke Unit (1)
- Strumpellin (1)
- Super-Resolution Microscopy (1)
- Synaptische Transmission (1)
- Synaptische Vesikel (1)
- Synthese (1)
- Synthesis (1)
- T Helper Cell (1)
- T Lymphocyte (1)
- T-Lymphozyt (1)
- T-Zellmigration (1)
- TAC (1)
- TLR3 (1)
- TRRAP (1)
- Tagesrhythmus (1)
- Targeted therapy (1)
- Temporal predictability (1)
- Theory of Mind (1)
- Therapie (1)
- Therapieresistenz (1)
- Thigmotaxis (1)
- Thrombose (1)
- Thrombosis (1)
- Thrombozytenfunktion (1)
- Tiermodell (1)
- Tissue staining (1)
- Transkription <Genetik> (1)
- Transplantatabstoßung (1)
- Transposon (1)
- Transthorakale Echokardiographie (1)
- Traumatic neuropathy (1)
- Treg (1)
- Trem2 (1)
- TruD (1)
- Trypanosoma (1)
- Trypanosoma brucei (1)
- Trypanosomiasis (1)
- Tumor (1)
- UBA6 (1)
- UBE2Z (1)
- Ubiquitylation (1)
- Ultraschall (1)
- VE-Cadherin (1)
- VE-PTP (1)
- VLA-1 (1)
- Validierungsstudie (1)
- Vasopressin (1)
- Vernetzung <Chemie> (1)
- Verwundbarkeit (1)
- Vibrationstraining (1)
- Virus infection (1)
- Visuelle Orientierung (1)
- Visuelle Wahrnehmung (1)
- Vitamin D (1)
- Vitamin D-Rezeptor (1)
- Vitamin D3 (1)
- Vorhersage (1)
- WASH complex (1)
- Wahrnehmung (1)
- Waiting Impulsivity (1)
- Web services (1)
- Wirkstoffdesign (1)
- Wnt-Signalweg (1)
- Wnt-pathway (1)
- Xiphophorus (1)
- YAP (1)
- Zebrafish (1)
- Zelldifferenzierung (1)
- Zellkern (1)
- Zellteilung (Zytokinese) (1)
- acceptance-based strategies (1)
- active zone (1)
- acute brain slices (1)
- adrenal incidentaloma (1)
- adrenocortical adenoma (1)
- adrenocortical carcinoma (1)
- aging (1)
- allogenic stem cell transplantation (1)
- allografts (1)
- alpha-IIb beta-3 (1)
- amygdala (1)
- anaerobe (1)
- anterior insula (1)
- anxiety disorders (1)
- artificial human skin (1)
- attention (1)
- bee-lining (1)
- benzimidazole (1)
- beta cell (1)
- beta-Catenin (1)
- biofabrication (1)
- bioink (1)
- biology (1)
- bitter taste (1)
- blood brain barrier (1)
- body axis (1)
- bone marrow (1)
- bone metastases (1)
- brain (1)
- calcium activity (1)
- cell migration (1)
- central complex (1)
- chromatin accessibility (1)
- cine loop (1)
- closing of chromatin (1)
- cognitive decline (1)
- collybistin (1)
- conformational activation (1)
- dendritic cells (1)
- developmental differentiation (1)
- dexamethasone suppression test (1)
- diagnostic accuracy (1)
- diet (1)
- differential RNA-seq (1)
- drift-diffusion model (1)
- early detection (1)
- echocardiography (1)
- electron tomography (1)
- electrophysiology (1)
- endosomal trafficking (1)
- enhancers (1)
- epigenetics (1)
- exposure therapy (1)
- expression (1)
- extinction (1)
- extracellular matrix (1)
- eye contact (1)
- fMRI time series (1)
- feasibility (1)
- feral bees (1)
- fluorescence resonance energy transfer (FRET) (1)
- fmri activity (1)
- forager (1)
- forest landscape (1)
- foxtapeworm (1)
- functional neuroimaging (1)
- functional resting-state connectivity (1)
- funktionelle Kernspintomographie (1)
- funktionelle Magnetresonanztomographie (1)
- funktionelle Resting-State Konnektivität (1)
- genetic modification (1)
- genetic screen (1)
- gp130 (1)
- haloacid dehalogenase phosphatase (1)
- high-pressure freezing/freeze substitution (1)
- honey bee density (1)
- hyaluronic acid (1)
- hydrogel (1)
- iPSCs (1)
- immediate early genes (1)
- immune evasion (1)
- inferior frontal gyrus (1)
- inflammatory pain (1)
- inhibitory postsynapse (1)
- innate immunity (1)
- ischämischer Schlaganfall (1)
- juvenile hormone (1)
- kinase (1)
- late enhancement (1)
- late gadolinium-enhancement (1)
- luciferase assay (1)
- lytic infection (1)
- macrophages (1)
- magnetic resonance imaging (1)
- malnourishment (1)
- mean first passage time (1)
- mesenchymal stem cells (1)
- metabolite repair (1)
- miRNA (1)
- miRNA target (1)
- miRNS (1)
- mild cognitive impairment (1)
- molecular mechanism (1)
- monarch butterfly (1)
- monocyte-derived dendritic cells (1)
- monozytenderivierte dendritische Zellen (1)
- mossy fiber synapse (1)
- multi-pinhole collimation (1)
- multi-unit recording (1)
- myeloablation (1)
- myocardial deformation (1)
- neuroinflammation (1)
- neurologin-2 (1)
- neuronal excitability (1)
- neuropaticher Schmerz (1)
- nurse bee (1)
- olfaction (1)
- opening of chromatin (1)
- orientation (1)
- p53 (1)
- pain regulation (1)
- pancreas (1)
- pancreatic cancer (1)
- pancreatic differentiation (1)
- perception (1)
- performance evaluation (1)
- peripheral nervous system (1)
- pharmacology (1)
- phosphoglycolate phosphatase (1)
- platelet (1)
- point-of-care (1)
- post-transcriptional regulation (1)
- potenzielles therapeutisches Target (1)
- presynaptic (1)
- quiescence (1)
- real-time imaging (1)
- reciprocity (1)
- regenerative medicine (1)
- regulatory RNA (1)
- reporter screen (1)
- responsiveness (1)
- reversible oxidation (1)
- ribosome biogenesis (1)
- self-targeting CRISPR-Cas (1)
- sigma factor (1)
- single particle tracking (1)
- single-cell RNA sequencing (1)
- single-molecule localization microscopy (1)
- skin equivalent (1)
- small RNA expression (1)
- small-animal SPECT (1)
- social understanding (1)
- specific phobia (1)
- speckle tracking (1)
- spezifische Phobie (1)
- spider phobia (1)
- spiral trajectory (1)
- spontaneous blinks (1)
- strain (1)
- strain rate (1)
- sugar perception (fructose, sucrose) (1)
- sugar receptor (1)
- super-resolution microscopy (1)
- systemic inflammation (1)
- tapeworm (1)
- temporo-parietal junction (1)
- thrombo-inflammation (1)
- thrombopoiesis (1)
- time-correlated single photon counting (TCSPC) (1)
- tissue engineering (1)
- transcription (1)
- transcriptional termination site (1)
- unklarer Signifikanz (1)
- validation study (1)
- vasp (1)
- vdr (1)
- ve-cadherin (1)
- viral genome packaging (1)
- viral miRNAs (1)
- vision (1)
- visual cue (1)
- visual perception (1)
- vitamin d (1)
- vitamin d receptor (1)
- waggle dance decoding (1)
- wax (1)
- wild-living honey bees (1)
- xiphophorus (1)
- zentrale Spindel und Mittelkörper (1)
- Überexpression (1)
Institute
- Graduate School of Life Sciences (130) (remove)
Sonstige beteiligte Institutionen
- Helmholtz Institute for RNA-based Infection Research (HIRI) (2)
- Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg (2)
- Carl-Ludwig-Institut für Physiologie, Universität Leipzig (1)
- Chair of Experimental Biomedicine I (1)
- Evangelisches Studienwerk e.V. (1)
- Fraunhofer Institute for Integrierte Schaltungen (IIS) (1)
- Helmholtz Center for RNA-based Infection Research (1)
- Helmholtz Institute for RNA-based Infection Research (1)
- Helmholtz-Institut für RNA-basierte Infektionsforschung (1)
- IZKF Research Laboratory Dept. Medicine II & Pediatrics (1)
Aging is known to be a risk factor for structural abnormalities and functional decline in the nervous system. Characterizing age-related changes is important to identify putative pathways to overcome deleterious effects and improve life quality for the elderly. In this study, the peripheral nervous system of 24-month-old aged C57BL/6 mice has been investigated and compared to 12-month-old adult mice. Aged mice showed pathological alterations in their peripheral nerves similar to nerve biopsies from elderly human individuals, with nerve fibers showing demyelination and axonal damage. Such changes were lacking in nerves of adult 12-month-old mice and adult, non-aged humans. Moreover, neuromuscular junctions of 24-month-old mice showed increased denervation compared to adult mice. These alterations were accompanied by elevated numbers of macrophages in the peripheral nerves of aged mice. The neuroinflammatory conditions were associated with impaired myelin integrity and with a decline of nerve conduction properties and muscle strength in aged mice.
To determine the pathological impact of macrophages in the aging mice, macrophage depletion was performed in mice by oral administration of CSF-1R specific kinase (c-FMS) inhibitor PLX5622 (300 mg/kg body weight), which reduced the number of macrophages in the peripheral nerves by 70%. The treated mice showed attenuated demyelination, less muscle denervation and preserved muscle strength. This indicates that macrophage-driven inflammation in the peripheral nerves is partially responsible for the age-related neuropathy in mice.
Based on previous observations that systemic inflammation can accelerate disease progression in mouse models of neurodegenerative diseases, it was hypothesized that systemic inflammation can exacerbate the peripheral neuropathy found in aged mice. To investigate this hypothesis, aged C57BL/6 mice were intraperitoneally injected with a single dose of lipopolysaccharide (LPS; 500 μg/kg body weight) to induce systemic inflammation by mimicking bacterial infection, mostly via activation of Toll-like receptors (TLRs). Altered endoneurial macrophage activation, highlighted by Trem2 downregulation, was found in LPS injected aged mice one month after injection. This was accompanied by a so far rarely observed form of axonal perturbation, i.e., the occurrence of “dark axons” characterized by a damaged cytoskeleton and an increased overall electron density of the axoplasm. At the same time, however, LPS injection reduced demyelination and muscle denervation in aged mice. Interestingly, TREM2 deficiency in aged mice led to similar changes to LPS injection. This suggests that LPS injection likely mitigates aging-related demyelination and muscle denervation via Trem2 downregulation.
Taken together, this study reveals the role of macrophage-driven inflammation as a pathogenic mediator in age-related peripheral neuropathy, and that targeting macrophages might be an option to mitigate peripheral neuropathies in aging individuals. Furthermore, this study shows that systemic inflammation may be an ambivalent modifier of age-related nerve damage, leading to a distinct type of axonal perturbation, but in addition to functionally counteracting, dampened demyelination and muscle denervation. Translationally, it is plausible to assume that tipping the balance of macrophage polarization to one direction or the other may determine the functional outcome in the aging peripheral nervous system of the elderly.
RNA is one of the most abundant macromolecules and plays essential roles in numerous biological processes. This doctoral thesis consists of two projects focusing on RNA structure and RNA-RNA interactions in viral genome packaging. In the first project I developed a method called Functional Analysis of RNA Structure (FARS-seq) to investigate structural features regulating genome dimerization within the HIV-1 5’UTR. Genome dimerization is a conserved feature of retroviral replication and is thought to be a prerequisite for binding to the viral structural protein Pr55Gag during genome packaging. It also plays a role in genome integrity and evolution through recombination, and is linked to a structural switch that may regulate genome packaging and translation within cells. Despite its importance for HIV-1 replication, the RNA signals regulating genome dimerization, and the molecular mechanism leading to the selection of the genome dimer over the monomer for packaging are incompletely understood. The FARS-seq method combines RNA structural information obtained by chemical probing with single nucleotide resolution profiles of RNA function obtained by mutational interference. In this way, we found nucleotides that were critical for dimerization, especially within the well-characterized dimerization motif within stem-loop 1 (SL1). We also found stretches of nucleotides that enhanced genome dimerization upon mutation, suggesting their role in negatively regulating dimerization. A structural analysis identified distinct structural signatures within monomeric and dimeric RNA. The dimeric conformation displayed the canonical transactivation response (TAR), PolyA, primer binding site (PBS), and SL1-SL3 stem-loops, and contained a long range U5-AUG interaction. Unexpectedly, in monomeric RNA, SL1 was reconfigured into long- and short-range base-pairings with PolyA and PBS, respectively. Intriguingly, these base pairings concealed the palindromic sequence needed for dimerization and disrupted the internal loop in SL1 previously shown to contain the major packaging motif for Pr55Gag. We therefore rationally introduced mutations into PolyA and PBS, and showed how these regions regulate genome dimerization, and the binding of Pr55Gag in vitro, as well as genome packaging into virions. These findings give insights into late stages of the HIV-1 life cycle and a mechanistic explanation for the link between RNA dimerization and packaging.
In the second project, I developed a proximity ligation and high-throughput sequencing-based method, RNA-RNA seq, which can measure direct (RNA-RNA) and indirect (protein-mediated) interactions. In contrast to existing methods, RNA-RNA seq is not limited by specific protein or RNA baits, nor to a particular crosslinking reagent. The genome of influenza A virus contains eight segments, which assemble into a “7+1” supramolecular complex. However, the molecular details of genome assembly are poorly understood. Our goal is to use RNA-RNA seq to identify the sites of interaction between the eight genomic RNAs of influenza, and to use this information to define the quaternary RNA architecture of the genome. We showed that RNA-RNA seq worked on model substrates, like the HIV-1 Dimerization Initiation Site (DIS) RNA and purified ribosome, as well as influenza A virus infected cells.
SUMOylation, as a post-translational modification, plays a crucial role in several biological processes. Small ubiquitin-like modifier (SUMO) proteins can be reversibly linked to the lysine residues located within specific motifs on numerous target proteins, leading to the change of stability, localization, activity of target proteins, mostly by promoting or interfering with the interaction with other molecules. Consequently, it can regulate gene transcription, migration, cell cycle progression, cellular responses to stress, and tumorigenesis.
NFATc1 belongs to the Nuclear Factor of Activated T-cells (NFAT) transcription factor family, which is dephosphorylated and translocates to the nucleus upon cell stimulation, which provokes Ca2+ signalling. NFAT plays a crucial role in the development and function of the immune system. NFATc1 has three SUMOylation sites at the position of aa 349, 702, and 914. In our previous study, we demonstrated that point mutations performed on the SUMOylation sites on all three or only at the lysine residues K702 and K914 lead to enhanced expression of IL-2 in vitro. To evaluate the function of SUMOylation of NFATc1 on T cell-mediated immunity in vivo, we not only generated a transgenic mouse strain (NFATc1/ΔS+ mouse) by point mutations from Lysine to Arginine on the two SUMOylation sites within exon 10 of Nfatc1 to prevent their SUMOylation, but in combination created another mouse strain (NFATc1/ΔBC+ mouse) that is completely Nfatc1 exon 10-ablated by using the LoxP/Cre system. In NFATc1/ΔS+ T cells, we observed enhanced IL-2 production and less IL-17A and IFN-γ expression. In line with exon 10 bearing the relevant SUMO sites, NFATc1/ΔBC+ CD4+ T cells behaved similarly as NFATc1/ΔS+ ones. The mechanism is that elevated IL-2 secretion can counteract the expression of IL-17A and IFN-γ via STAT5 and Blimp-1 induction. Afterwards, Blimp-1 suppressed IL-2 itself as well as Bcl2A1. Next, we performed two disease models with our NFATc1/ΔS+ mice. In a major mismatch model for acute graft-versus-host disease, we found that the mice transplanted with NFATc1/ΔS+ CD3+ T cells developed less severe disease, and T cells proliferated less due to increased Tregs. Moreover, when transferring 2D2.NFATc1/ΔS+ Th1 plus Th17 cells to Rag1-/- mice to induce experimental autoimmune encephalitis, we also observed ameliorated disease compared to animals with transferred WT T cells as well as increased Tregs.
Taking all data together, the deficiency in SUMOylation of NFATc1 leads to an elevated IL-2 secretion in T cells and subsequent activation of STAT5, which competes with STAT3 to inhibit IL-17A production and promotes Treg expansion, as well as to an enforcement of Blimp-1 expression, which suppresses IFN-γ and IL-2 expression. Consequently and despite a short phase of enhanced IL-2 secretion, the deficiency of SUMOylation on NFATc1 can protect from autoreactive and alloreactive diseases.
Moreover, to further understand the function of SUMOylation of NFATc1 in humans, we started by establishing an in vitro 3D culture system for tonsil organoids, which was successful in the presence of feeder cells, along with IL-4 and IL-7 cytokines. To confirm that our 3D tonsil organoids can respond to real antigens, we used CMV peptides and peptides of spike proteins from Covid-19 as real antigens, and co-cultured with tonsil organoids, which indeed can generate memory cells and plasmablasts. In the end, we also compared 3D to 2D cultures. Although the total numbers of all B cell subsets were much less in 3D culture than that in 2D culture, still, it indicates that this in-vitro culture system has its limitation, while being usable to produce the similar results as 2D did. Therefore, this 3D culture system can be used as a platform to investigate NFATc1/ΔS+ or NFATc1/ΔBC+ TFH and TFR cells in the dynamic of human GC responses.
CRISPR-Cas systems are highly diverse and canonically function as prokaryotic adaptive immune systems. The canonical resistance mechanism relies on spacers that are complementary to the invaders' nucleic acids. By accidental incorporation or other mechanisms, prokaryotes can also acquire self-targeting spacers that are complementary to their own genome. As self-targeting commonly leads to lethal autoimmunity, the existence of self-targeting spacers poses a paradox. In Chapter 1, we provide an overview of the prevalence of self-targeting spacers, summarize how they can be incorporated, and which means can be employed by the host to evade lethal self-targeting. In addition, we outline alternative functions of CRISPR-Cas systems that are associated with self-targeting spacers. Whether CRISPR-Cas systems can efficiently target their own genome depends heavily on the presence of protospacer adjacent motifs (PAMs) next to the target region. In Chapter 2, we developed a method to determine PAM requirements. Thereby, we specifically focused on type I systems that engage multi-protein complexes, which are challenging to assess. Using the cell-free transcription-translation (TXTL) system, we developed an enrichment-based binding assay and validated its reliability by examining the well-known PAM requirements of the E. coli type I-E system. In Chapter 3, we applied the TXTL-based PAM assay to assess 16 additional CRISPR-Cas systems. These 16 systems included three CRISPR-Cas associated transposons (CASTs). CASTs are recently discovered transposons that employ CRISPR-Cas systems in a non-canonical function for the directed integration of the transposon. To further characterize CASTs in TXTL outside their PAM requirements, we reconstituted the transposition of CASTs in TXTL. In Chapter 4, we turned to non-canonical self-targeting CRISPR-Cas systems, which were already discussed in Chapter 1. While investigating how the plant pathogen Xanthomonas albilineans survives self-targeting by its two endogenous CRISPR-Cas systems, we identified multiple putative anti-CRISPR proteins (Acrs) in the genome of X. albilineans. Two of the Acrs, named AcrIC11 and AcrIF12Xal, inhibited degradation by their respective CRISPR-Cas systems but still retained Cascade-binding ability, and appear responsible for the lack of autoimmunity in X. albilineans. In summary, we developed new technologies that eased the investigation of non-canonical multi-component systems and, if applied to additional systems, might reveal unique properties that could be implemented in new CRISPR-Cas based tools.
Untersucht wurde der Einfluss mehrerer Chemotherapeutika auf den Chemokinrezeptor CXCR4 in
Myelomzelllinien auf Ebene des Promotors, der mRNA und der Rezeptorverteilung, wobei drei
Substanzen (Etoposid, Bortezomib und Dexamethason) als potenzielle Suppressoren des Promotors ausgemacht werden konnten. Abhängig vom Myelom-Zelltyp und der Dosierung können so evtl.
Rückschlüsse auf die beobachtete Suppression von CXCR4 bei erkrankten Patienten mit hoher CXCR4-Aktivität (hier: Malignes Myelom) durch die begleitende Chemotherapie gezogen werden, welche eine Diagnostik und Therapie bei diesen Patienten erschwert.
Hintergrund: Hintergrund für diese Arbeit waren Beobachtungen in klinischen Fallstudien von Lapa et al. am Universitätsklinikum Würzburg, die sich auf CXCR4 bezogen, welches u.a. bei Patienten mit
Multiplem Myelom überexprimiert wird und dadurch bereits als Target für Diagnostik und Therapie in der Klinik Anwendung findet. Dabei konnte bei PET-CT Untersuchungen in der Nuklearmedizin beobachtet werden, dass es durch die begleitende Chemotherapie der Patienten zu einer Suppression des markierten CXCR4-Signals kam, so dass es nicht mehr zur Verlaufsbeobachtung und
vor allem nicht mehr zur Radiotherapie und Therapiekontrolle verwendet werden konnte.
Um den Einfluss und mögliche Interaktionen der Chemotherapeutika auf CXCR4 zu untersuchen, war es Ziel dieser Arbeit, ein vergleichbares Szenario in-vitro nachzustellen und Einflüsse messbar zu
machen, um so mögliche Ansätze und Verbesserungsvorschläge für die klinische Anwendung zu
liefern.
Methoden/Ergebnisse: Hierfür wurden im ersten Teil INA-6 (Myelomzellen) und Mesenchymale
Stammzellen (MSC) kultiviert, in Ko-Kultur gebracht und nach einer bestimmten Zeit wieder getrennt, um anschließend den gegenseitigen Einfluss in Bezug auf CXCR4 zu messen. Zudem wurde der Einfluss von Dexamethason untersucht. Es zeigte sich eine enge Bindung zwischen INA-6 und MSC
sowie eine hohe CXCR4-Aktivität bei INA-6, jedoch konnte keine Induktion der CXCR4-Aktivität in MSC durch INA-6-Kontakt oder Dexamethason quantifiziert werden. Die Immunzytologie erwies sich aufgrund einer schweren Anfärbbarkeit von CXCR4 – auch mit verschiedensten Antikörpern und sogar Liganden-gekoppeltem Farbstoff– als kaum auswertbar, wobei eine Darstellung von CXCR4
generell aber gelang.
Der CXCR4-Promotor wurde mittels Software genauer analysiert, wobei einige relevante Bindestellen, u.a. für Glukokortikoide und NFkB gefunden wurden. Die Herstellung eines CXCR4-
pGl4.14-Promotor-Konstrukts war erfolgreich, ebenso dessen Einschleusung in Myelomzellen. Auch gelang die Herstellung stabiler transfizierter INA-6, sodass mit diesen anschließend konstantere Ergebnisse erzielt werden konnten.
Im größten Teil der Arbeit wurden geeignete Chemotherapeutika-Konzentrationen ermittelt und in Viabilitäts- und Apoptose-Versuchen überprüft. Die Stimulationsversuche mit diesen zeigten variable
Effekte abhängig vom Zelltyp (INA-6, MM1S), jedoch konnten Bortezomib, Etoposid und
Dexamethason konzentrationsabhängig als starke Suppressoren der CXCR4-Aktivität ausgemacht
werden, was sich v.a. auf Ebene der Promotoraktivität – gemessen mittels Luciferase - zeigte. Interpretation: In-vitro konnten somit drei potenzielle Suppressoren der CXCR4-Aktivität ausgemacht
werden: Etoposid, Bortezomib und Dexamethason. Zumindest beim INA-6-Zelltyp fiel dieser Effekt deutlich aus, wobei in der Klinik der entsprechende Zelltyp sowie die Dosierung der Medikamente berücksichtigt werden müssen. Hinzu kommen weitere Einflussfaktoren des menschlichen Körpers,
die nicht berücksichtig werden konnten. Die genauen Mechanismen der Suppression könnten sich aus den Bindestellen des Promotors erklären, die von uns analysiert wurden, aber auf die in weiteren Arbeiten noch näher eingegangen werden muss.
Despite accounting for only a small proportion of all skin cancers, malignant melanoma
displays a serious health risk with increasing incidence and high mortality rate. Fortunately,
advances in the treatment of malignant melanoma now prolong survival and enhance response
and treatment efficacy. Established biomarkers help evaluate disease progression and
facilitate choosing appropriate and individual treatment options. However, the need for easily
accessible and reliable biomarkers is rising to predict patient-specific clinical outcome.
Eosinophil infiltration into the tumor and high peripheral eosinophil counts prior and during
treatment have been associated with better response in patients for various cancer entities,
including melanoma. An analysis of a heterogeneous study cohort reported high serum ECP
levels in non-responders. Hence, eosinophil frequency and serum ECP as a soluble
eosinophil-secreted mediator were suggested as prognostic biomarkers in melanoma. We
examined whether melanoma patients treated with first-line targeted therapy could also benefit
from the effects of eosinophils. In total, 243 blood and serum samples from patients with
advanced melanoma were prospectively and retrospectively collected before and after drug
initiation. To link eosinophil function to improved clinical outcome, soluble serum markers and
peripheral blood counts were used for correlative studies using a homogeneous study cohort.
In addition, functional and phenotypical characterizations provided insights into the expression
profile and activity of freshly isolated eosinophils, including comparisons between patients and
healthy donors.
Our data showed a significant correlation between high pre-treatment blood eosinophil counts
and improved response to targeted therapy and by trend to combinatorial immunotherapy in
patients with metastatic melanoma. In accordance with previous studies our results links
eosinophil blood counts to better response in melanoma patients. High pre-treatment ECP
serum concentration correlated with response to immunotherapy but not to targeted therapy.
Eosinophils from healthy donors and patients showed functional and phenotypical similarities.
Functional assays revealed a strong cytotoxic potential of blood eosinophils towards
melanoma cells in vitro, inducing apoptosis and necrosis. In addition, in vitro cytotoxicity was
an active process of peripheral eosinophils and melanoma cells with bidirectional features and
required close cell-cell interaction. The extent of cytotoxicity was dose-dependent and showed
susceptibility to changes in physical factors like adherence. Importantly, we provide evidence
of an additive tumoricidal function of eosinophils and combinatorial targeted therapy in vitro. In
summary, we give valuable insights into the complex and treatment-dependent role of
eosinophils in melanoma. As a result, our data support the suggestion of eosinophils and their
secreted mediators as potential prognostic biomarkers. It will take additional studies to
examine the molecular mechanisms that underlie our findings.
Sepsis ist eine dysregulierte Reaktion des Organismus auf eine Infektion. Bei Sepsis werden oft Blutungs- und Thromboseereignisse beobachtet, welche in einer Disseminierten Intravasalen Gerinnung (DIG) gipfeln können. Thrombozyten sind die Schlüsselzellen von Thrombose und Hämostase. Bei Sepsis und DIG kommt es häufig zu einem Abfall der Thrombozytenzahl, doch Blutungs- und Thromboseereignisse können unabhängig von der Thrombozytenzahl auftreten, was zusätzlich eine Veränderung der Thrombozytenfunktion nahelegt.
In dieser Arbeit wurde deshalb die Thrombozytenfunktion bei 15 Patienten mit Sepsis zu drei Zeitpunkten im Krankheitsverlauf untersucht. Es konnte bei unauffälliger Rezeptorexpression keine Voraktivierung der Thrombozyten mittels Durchflusszytometrie festgestellt werden. Jedoch war die Aktivierung nach Stimulation mit multiplen Agonisten signifikant reduziert. Besonders ausgeprägt war die Hyporeaktivität bei Stimulation des Kollagen-Rezeptors GPVI mit dem Agonisten CRP-XL. Es wurde gezeigt, dass nach GPVI-Stimulation eine reduzierte Phosphorylierung der nachgeschalteten Proteine Syk und LAT im Vergleich zum Gesundspender induziert wird. In Kreuzinkubationsexperimenten hatte die (Co )Inkubation von Thrombozyten in Plasma von Sepsispatienten oder mit Bakterienisolaten aus Sepsis-Blutkulturen keinen Effekt auf die Thrombozytenreaktivität. Allerdings konnte durch Sepsis-Vollblut eine signifikante GPVI-Hyporeaktivität in Thrombozyten von gesunden Probanden induziert werden, was einen zellulären Mediator als Ursache des Defekts nahelegt. In dieser Arbeit wurde gezeigt, dass insbesondere die GPVI-Signalkaskade bei Sepsis massiv beeinträchtigt ist. Der Immunorezeptor GPVI ist ein vielversprechendes Zielmolekül, um die Pathogenese der Sepsis, des Capillary Leak und die immunregulatorische Rolle von Thrombozyten besser zu verstehen. Die GPVI-Hyporeaktivität könnte als zukünftiger Biomarker für die Sepsis-Frühdiagnose genutzt werden.
This thesis aimed the development of a correlated device which combines FluidFM® with Fluorescence Microscopy (FL) (FL-FluidFM®) and enables the simultaneous quantification of adhesion forces and fluorescent visualization of mature cells. The implementation of a PIFOC was crucial to achieve a high-resolution as well as a stable but dynamic focus level. The functionality of SCFS after hardware modification was verified by comparing two force-curves, both showing the typical force progression and measured with the optimized and conventional hardware, respectively. Then, the integration of FL was examined by detaching fluorescently labeled REF52 cells. The fluorescence illumination of the cytoskeleton showed the expected characteristic force profile and no evidence of interference effects. Afterwards a corresponding correlative data analysis was addressed including manual force step fitting, the identification of visualized cellular unbinding, and a time-dependent correlation. This procedure revealed a link between the area of cytoskeletal unbinding and force-jumps. This was followed by a comparison of the detachment characteristics of intercellular connected HUVECs and individual REF52 cells. HUVECs showed maximum detachment forces in the same order of magnitude as the ones of single REF52 cells. This contrasted with the expected strong cohesiveness of endothelial cells and indicated a lack of cell-cell contact formation. The latter was confirmed by a comparison of HUVECs, primary HBMVECs, and immortalized EA.hy926 cells fluorescently labeled for two marker proteins of intercellular junctions. This unveiled that both the previous cultivation duration and the cell type have a major impact on the development of intercellular junctions. In summary, the correlative FL FluidFM® represents a powerful novel approach, which enables a truly contemporaneous performance and, thus, has the potential to reveal new insights into the mechanobiological properties of cell adhesion.
The human body has very good self-healing capabilities for numerous different injuries to a variety of different tissues. This includes the main human mechanical framework, the skeleton. The skeleton is limited in its healing without additional aid by medicine mostly by the defect size. When the defect reaches a size above 2.5 cm the regeneration of the defect ends up faulty. Here is where implants, defect fillers and other support approaches developed in medicine can help the body to heal the big defect still successfully.
Usually sturdy implants (auto-/allo-/xenogenic) are implanted in the defect to bridge the distance, but for auto- and allogenic implants a suitable donor site must be found and for all sources the implant needs to be shaped into the defect specific site to ensure a perfect fit, the best support and good healing. This shaping is very time consuming and prone to error, already in the planning phase. The use of a material that is moldable and sets in the desired shape shortly after applying negates these disadvantages. Cementitious materials offer exactly this property by being in a pasty stage after the powder and liquid components have been mixed and the subsequently hardening to a solid implant. These properties also enable the extrusion, and therefore may also enable the injection, of the cement via a syringe in a minimal invasive approach.
To enable a good injection of the cement modifications are necessary. This work aimed to modify commonly used calcium phosphate-based cement systems based on α-TCP (apatitic) and β-TCP (brushitic). These have been modified with sodium phytate and phytic acid, respectively. Additionally, the α-TCP system has been modified with sodium pyrophosphate, in a second study, to create a storable aqueous paste that can be activated once needed with a highly concentrated sodium orthophosphate solution.
The powder phase of the α-TCP cement system consisted of nine parts α-TCP and one part CDHA. These were prepared to have different particle sizes and therefore enable a better powder flowability through the bimodal size distribution. α-TCP had a main particle size of 20 μm and CDHA of 2.6 μm. The modification with sodium phytate led to an adsorption of phytate ions on the surface of the α-TCP particles, where they started to form complexes with the Ca2+ ions in the solution. This adsorption had two effects. The first was to make the calcium ions unavailable, preventing supersaturation and ultimately the precipitation of CDHA what would lead to the cement hardening. The second was the increase of the absolute value of the surface charge, zeta potential, of the powder in the cement paste. Here a decrease from +3 mV to -40 mV could be measured. A strong value for the zeta potential leads to a higher repulsion of similarly charged particles and therefore prevents powder agglomeration and clogging on the nozzle during injection. These two modifications (bimodal particles size distribution and phytic acid) lead to a significant increase in the paste injectability. The unmodified paste was injectable for 30 % only, where all modified pastes were practically fully injectable ~90 % (the residual paste remained in the nozzle, while the syringe plunger already reached the end of the syringe).
A very similar observation could be made for the β-TCP system. This system was modified with phytic acid. The zeta potential was decreased even stronger from -10 ± 1.5 mV to -71.5 ± 12 mV. The adsorption of the phytate ions and subsequent formation of chelate complexes with the newly dissolved Ca2+ ions also showed a retarding effect in the cements setting reaction. Where the unmodified cement was not measurable in the rheometer, as the reaction was faster than the measurement setup (~1.5 min), the modified cements showed a transition through the gel point between 3-6 min. This means the pastes stayed between 2 and 4 times longer viscous than without the modification. Like with the first cement system also here the effects of the phytate addition showed its beneficial influence in the injectability measurement. The unmodified cement was not injectable at all, due to the same issue already encountered at the rheology measurements, but all modified pastes were fully injectable for at least 5 min (lowest phytate concentration) and at least 10 min (all other concentrations) after the mixing of powder and liquid.
The main goal of the last modification with sodium pyrophosphate was to create a paste that was stable in aqueous environment without setting until the activation takes place, but it should still show good injectability as this was the desired way of application after activation. Like before also the zeta potential changed after the addition of pyrophosphate. It could be lowered from -22 ± 2mV down to -61 to -68 ± 4mV (depending on the pyrophosphate concentration). The pastes were stored in airtight containers at room temperature and checked for their phase composition over 14 days. The unmodified paste showed a beginning phase conversion to hydroxyapatite between 7 and 14 days. All other pastes were still stable and unreacted. The pastes were activated with a high concentrated (30 wt%) sodium orthophosphate solution. After the activation the pastes were checked for their injectability and showed an increase from -57 ± 11% for the unmodified paste to -89 ± 3% (practically fully injectable as described earlier) for the best modified paste (PP005).
It can be concluded that the goal of enabling full injection of conventional calcium phosphate bone cement systems was reached. Additional work produced a storage stable paste that still ensures full injectability. Subsequent work already used the storable paste and modified it with hyaluronic acid to create an ink for 3D extrusion printing. The first two cement systems have also already been investigated in cell culture for their influence on osteoblasts and osteoclasts. The next steps would have to go more into the direction of translation. Figuring out what properties still need to be checked and where the modification needs adjustment to enable a clinical use of the presented systems.
Kontraktion und Relaxation sind die beiden entscheidenden energieverbrauchenden Prozesse der Herzarbeit, die sich unter anderem mit modernen echokardiographischen Techniken, wie dem Strain Imaging, quantifizieren lassen. An 1818 Probanden (52% weibliche Probanden, mittleres Alter 54 ±12 Jahre) der populationsbasierten Würzburger STAAB Kohortenstudie leiteten wir unter Berücksichtigung von Alter und Geschlecht der Probanden Referenzwerte für globale und segmentale systolische und diastolische Deformationsparameter mittels 2D Speckle Echo-Tracking ab.
Wir fanden, dass sich die myokardiale Suszeptibilität für klassische kardiovaskuläre Risikofaktoren bei Männern und Frauen unterscheidet. Insgesamt war die Auswertbarkeit gut (67% des globalen Strain, 82% der systolischen und frühdiastolischen Strain Rate und 83% der diastolischen Strain Rate). Arterieller Hypertonus und Dyslipidämie wirkten sich insbesondere auf das weibliche Myokard ungünstig aus, wohingegen der Risikofaktor Adipositas bei beiden Geschlechtern negativ mit systolischer und frühdiastolischer Deformation assoziiert war.
Weder Diabetes mellitus noch Rauchen schienen die myokardiale Deformation zu beeinflussen. Die frühdiastolische Relaxation wurde durch Hypertonus negativ bei Frauen beeinflusst, obwohl die Prävalenz in der männlichen Gruppe höher war. Die systolische Strain Rate war zudem signifikant von arteriellem Hypertonus, Dyslipidämie und Adipositas bei Frauen beeinflusst. Diese Ergebnisse implizieren eine geschlechtsabhängige Sensitivität des Myokards auf individuelle Risikofaktoren. Die Vulnerabilität des weiblichen Myokards auf hypertone Blutdruckwerte mit konsekutiver Alteration der aktiven frühdiastolischen Relaxation stellt somit eine mögliche Erklärung für den größeren Anteil an Frauen mit HFpEF (heart failure with preserved ejection fraction) in der Allgemeinbevölkerung dar.
Ein negativer Einfluss durch Nikotinkonsum war in unserem Ansatz hingegen nicht nachweisbar, in dem nicht das Ausmaß des Nikotinkonsums, sondern nur die Assoziation der binären Variable „Raucherstatus“ mit Strain-Parameternuntersucht wurde. Dahingehend ist eine dosisabhängige myokardiale Schädigung nicht auszuschließen.
In der vorliegenden Studie wurde erstmalig der individuelle Effekt jedes Hauptrisikofaktors auf systolische und diastolische Strain-Parameter in einer populationsbasierten und nach Geschlecht und Alter stratifizierten Kohorte untersucht. Auf Basis der Studienergebnisse ist jetzt eine objektive Abschätzung von Effektgrößen und der Power für künftige Studienplanung möglich und es lassen sich Studien zur Einordnung der myokardialen Deformation in bestimmten Patientengruppen objektivierbar vergleichen.
Unsere Ergebnisse unterstreichen zudem die Notwendigkeit von Studien bezüglich Primärprävention asymptomatischer kardiovaskulärer Risikopatienten mittels nichtinvasiver Methoden. Eine wichtige Rolle kommt dabei auch der Standardisierung von Softwaresystemen zu, die die Anwendung im klinischen Alltag und die globale Anwendung von Referenzwerten bzw. deren pathologischer Abweichung vereinfachen wird.